Jackson Financial is a retirement solutions provider whose results are closely watched as a barometer of demand for annuities and of the spread income insurers earn between investment yields and policyholder payouts. The third quarter of 2026 tested whether the company could sustain the momentum from a strong first half, when adjusted EPS consistently beat expectations and retail annuity sales climbed sharply. Rising interest rates, equity market performance, and distribution strength all feed directly into Jackson's spread-based business model. The quarter also carried added significance following a leadership transition, with Don Cummings taking over as president and CEO, and the newly announced AARP annuity partnership positioning the company for broader distribution reach. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Jackson Financial reported adjusted operating earnings per common share (diluted) of $7.55 for the third quarter of 2026, exceeding analyst consensus estimates that clustered near $7.03 to $7.24. Pretax adjusted operating earnings totaled $612 million, up from $505 million in the same period a year earlier, powered by a Retail Annuities segment that contributed $638 million versus $494 million in the prior year.
On the top line, total revenue of approximately $1.54 billion came in below the roughly $2.06 billion consensus, though the shortfall largely reflects how investment and hedging-related items flow through the income statement rather than a decline in underlying customer demand. Retail annuity sales hit a record $6.5 billion, up 22% year over year, led by record RILA sales of $3.0 billion. Fixed annuity and fixed index annuity (FIA) sales also advanced, while variable annuity (VA) sales edged slightly lower.
Capital metrics remained a highlight. Free capital generation reached $281 million in the quarter, and the company returned $291 million to common shareholders. Adjusted book value per diluted share rose to $164.47, up from $155.78 at the end of 2025, and holding-company cash stood at nearly $1.4 billion, well above the targeted minimum liquidity buffer.
Shares of JXN traded modestly higher in immediate after-hours activity, rising about 1.7% to near $143 shortly after the release, according to market data. The reaction suggests investors focused on the adjusted EPS beat and the record annuity sales, rather than the headline revenue miss, which is widely understood to be distorted by accounting for hedging and guaranteed-benefit items. The company's continued free capital generation and shareholder returns also supported a constructive tone. Sentiment entering the quarter had been positive following consecutive EPS beats, and the results reinforced that view despite the top-line shortfall.
Looking ahead, investors should watch whether Jackson Financial can sustain its record-setting sales pace in a competitive annuity market. The newly announced exclusive AARP annuity program is a notable catalyst, potentially expanding distribution to millions of additional consumers, though its contribution will build gradually rather than all at once.
Spread income, the difference between investment yields and crediting rates paid to policyholders, remains the central earnings driver. Continued strength in equity markets and stable-to-higher interest rates would support this dynamic, while declining rates or market volatility could compress spreads.
Capital deployment is another key focus. Jackson's ability to keep generating free capital and returning cash to shareholders, while funding new business growth and maintaining its risk-based capital (RBC) ratio, will shape investor confidence. The integration of the leadership transition under CEO Don Cummings and the ongoing partnership with asset manager TPG are additional factors to monitor in the quarters ahead.
When analyzing results like these, I find it helpful to run quick comparisons with Tickeron’s AI Screener. This tool lets me filter across technical patterns, fundamentals, and industry peers in a structured way, which can highlight where JXN stands relative to similar names and spot potential shifts in market conditions. It keeps the process efficient without replacing core fundamental review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for JXN crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on JXN as a result. In 62 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for JXN just turned positive on October 22, 2026. Looking at past instances where JXN's MACD turned positive, the stock continued to rise in 31 of 44 cases over the following month. The odds of a continued upward trend are 70%.
JXN moved above its 50-day moving average on October 26, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where JXN advanced for three days, in 293 of 379 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 203 of 275 cases where JXN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JXN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
JXN broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. JXN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.989) is normal, around the industry mean (1.339). JXN's P/E Ratio (149.609) is considerably higher than the industry average of (19.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.463). Dividend Yield (0.026) settles around the average of (0.047) among similar stocks. P/S Ratio (1.511) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry LifeHealthInsurance